EPCAM and ovarian carcinoma: Importantly, we showed that EpCAM-siPKCι aptamer suppressed intraperitoneal tumor development of PRKCI-amplified ovarian cancer cells and prolonged lifespan of tumor-bearing mice (Fig. 6).